TysonBio expands into India
This article was originally published in Clinica
Taiwanese manufacturer of blood glucose monitoring systems Tyson Bioresearch (TysonBio) has struck two distribution deals in India in a bid to grow its geographic footprint. The firm has enlisted New Delhi-based Lifeline Surgicals and Regenix Drugs, based in Chennai, to cover both the northern and southern Indian regions, respectively. TysonBio's CE-marked and FDA-cleared blood glucose meters, the EZ Smart and Diachex, integrate biosensor and proprietary compressed data memory micro-ship technologies to enable the devices to work three times as fast as those with standard chips, says the Chunan-based company.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.